合约研发生产组织（CDMO）－2026-2032年全球市占率及排名、总收入及需求预测

2025 年全球合约开发和生产组织 (CDMO) 的市场规模估计为 146.31 亿美元，预计从 2026 年到 2032 年将以 7.24% 的复合年增长率增长，到 2032 年达到 2421.35 亿美元。

2025 年北美合约开发和生产组织 (CDMO) 市场价值为 443.36 亿美元，预计从 2026 年到 2032 年将以 6.43% 的复合年增长率增长，到 2032 年达到 693.67 亿美元。

2025年亚太地区合约开发生产组织（CDMO）市值为535.77亿美元，预计从2026年到2032年将以7.88%的复合年增长率增长，到2032年达到922.91亿美元。

主要企业包括Lonza、Catalent、Thermo Fisher Scientific、Samsung Biologics、Falev、Wuxi Aptech、Siegfried、 FUJIFILM Diosin Biotechnologies和Asinchem。预计到2025年，排名前五的公司将占据市场收入的约14.15%。

本报告全面分析了全球合约开发和生产组织 (CDMO) 市场，涵盖总收入、市场份额和主要企业的排名，以及按地区/国家、类型和应用进行的分析。

本报告以收入（百万美元）为基础，对合约研发生产组织（CDMO）市场规模、估值和预测进行了阐述，以2025年为基准年，并涵盖了2021年至2032年的历史数据和预测数据。本报告结合定量和定性分析，旨在帮助读者制定成长策略、评估竞争格局、了解自身当前的市场地位，并就CDMO业务做出明智的决策。

市场区隔

公司

• Lonza
• Catalent
• Thermo Fisher Scientific
• Samsung Biologics
• Fareva
• WuXi AppTech
• WuXi Biologics
• Siegfried
• FUJIFILM Diosynth Biotechnologies
• Vetter
• Boehringer Ingelheim
• AGC Pharma Chemicals
• Pfizer CentreOne
• Delpharm
• Curia
• Aenova
• Recipharm
• Piramal
• Asymchem
• Strides Pharma
• Porton
• NextPharma
• Jubilant
• Euroapi
• Famar
• Eurofins
• Avid Bioservices
• Alcami
• BioVectra
• CPL

按类型分類的细分市场

• API CDMO
• FDF CDMO
• 包装 CDMO
• 临床CDMO

特定用途的剪辑

• 製药公司
• 生技公司
• 其他的

按地区分類的消费状况

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 亚太地区
  • 中国
  • 日本
  • 韩国
  • 东南亚
  • 印度
  • 亚太其他地区
• 欧洲
  • 德国
  • 法国
  • 英国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 南美洲
  • 巴西
  • 南美洲其他地区
• 中东和非洲
  • 中东
  • 非洲

The global market for Contract Development and Manufacturing Organizations (CDMOs) was estimated to be worth US$ 14631 million in 2025 and is projected to reach US$ 242135 million, growing at a CAGR of 7.24% from 2026 to 2032.

The North American market for Contract Development and Manufacturing Organizations (CDMOs) was valued at US$ 44336 million in 2025 and is projected to reach US$ 69367 million by 2032, at a CAGR of 6.43% from 2026 to 2032.

The Asia-Pacific market for Contract Development and Manufacturing Organizations (CDMOs) was valued at $ 53577 million in 2025 and is projected to climb to US$ 92291 million by 2032, at a CAGR of 7.88% from 2026 to 2032.

The global key companies in the Contract Development and Manufacturing Organizations (CDMOs) market include Lonza, Catalent, Thermo Fisher Scientific, Samsung Biologics, Fareva, WuXi AppTech, WuXi Biologics, Siegfried, FUJIFILM Diosynth Biotechnologies, Asymchem, etc. In 2025, the five largest players accounted for approximately 14.15% of revenue.

This report provides a comprehensive view of the global market for Contract Development and Manufacturing Organizations (CDMOs), covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Contract Development and Manufacturing Organizations (CDMOs) market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Contract Development and Manufacturing Organizations (CDMOs).

Market Segmentation

By Company

• Lonza
• Catalent
• Thermo Fisher Scientific
• Samsung Biologics
• Fareva
• WuXi AppTech
• WuXi Biologics
• Siegfried
• FUJIFILM Diosynth Biotechnologies
• Vetter
• Boehringer Ingelheim
• AGC Pharma Chemicals
• Pfizer CentreOne
• Delpharm
• Curia
• Aenova
• Recipharm
• Piramal
• Asymchem
• Strides Pharma
• Porton
• NextPharma
• Jubilant
• Euroapi
• Famar
• Eurofins
• Avid Bioservices
• Alcami
• BioVectra
• CPL

Segment by Type

• API CDMO
• FDF CDMO
• Packaging CDMO
• Clinical CDMO

Segment by Application

• Pharmaceutical Company
• Biotechnology Company
• Other

Consumption by Region

• North America
  • United States
  • Canada
  • Mexico
• Asia Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Rest of South America
• Middle East & Africa
  • Middle East
  • Africa

Chapter Outline

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Contract Development and Manufacturing Organizations (CDMOs) companies' competitive landscape-including sales and revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market classification, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Contract Development and Manufacturing Organizations (CDMOs) revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Contract Development and Manufacturing Organizations (CDMOs) revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Contract Development and Manufacturing Organizations (CDMOs) Product Introduction
• 1.2 Global Contract Development and Manufacturing Organizations (CDMOs) Market Size Forecast (2021-2032)
• 1.3 Contract Development and Manufacturing Organizations (CDMOs) Market Trends & Drivers
  • 1.3.1 Contract Development and Manufacturing Organizations (CDMOs) Industry Trends
  • 1.3.2 Contract Development and Manufacturing Organizations (CDMOs) Market Drivers & Opportunities
  • 1.3.3 Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
  • 1.3.4 Contract Development and Manufacturing Organizations (CDMOs) Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Contract Development and Manufacturing Organizations (CDMOs) Players Revenue Ranking (2025)
• 2.2 Global Contract Development and Manufacturing Organizations (CDMOs) Revenue by Company (2021-2026)
• 2.3 Key Companies' R&D and Operations Footprint and Headquarters
• 2.4 Key Companies Contract Development and Manufacturing Organizations (CDMOs) Product Offerings
• 2.5 Key Companies Founded Date Contract Development and Manufacturing Organizations (CDMOs)
• 2.6 Contract Development and Manufacturing Organizations (CDMOs) Market Competitive Analysis
  • 2.6.1 Contract Development and Manufacturing Organizations (CDMOs) Market Concentration Rate (2021-2026)
  • 2.6.2 Top 5 and Top 10 Global Companies by Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2025
  • 2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Contract Development and Manufacturing Organizations (CDMOs) revenue, 2025
• 2.7 Mergers & Acquisitions and Expansion

3 Segmentation Contract Development and Manufacturing Organizations (CDMOs) Market Classification

• 3.1 Introduction by Type
  • 3.1.1 API CDMO
  • 3.1.2 FDF CDMO
  • 3.1.3 Packaging CDMO
  • 3.1.4 Clinical CDMO
  • 3.1.5 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Pharmaceutical Company
  • 4.1.2 Biotechnology Company
• 4.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application
  • 4.2.1 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (2021-2032)
  • 4.2.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (2021-2032)
  • 4.2.3 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2021-2032

5 Segmentation by Region

• 5.1 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region
  • 5.1.1 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region: 2021 vs 2025 vs 2032
  • 5.1.2 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (2021-2026)
  • 5.1.3 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (2027-2032)
  • 5.1.4 Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (%), 2021-2032
• 5.2 North America
  • 5.2.1 North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 5.2.2 North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032
• 5.3 Europe
  • 5.3.1 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 5.3.2 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 5.4.2 Asia Pacific Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Subregion (%), 2025 vs 2032
• 5.5 South America
  • 5.5.1 South America Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 5.5.2 South America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 5.6.2 Middle East & Africa Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Contract Development and Manufacturing Organizations (CDMOs) Sales Value Growth Trends, 2021 vs 2025 vs 2032
• 6.2 Key Countries/Regions Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
• 6.3 North America
  • 6.3.1 North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 6.3.2 North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
  • 6.3.3 North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2025 vs 2032
• 6.4 Europe
  • 6.4.1 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 6.4.2 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
  • 6.4.3 Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2025 vs 2032
• 6.5 China
  • 6.5.1 China Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 6.5.2 China Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
  • 6.5.3 China Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2025 vs 2032
• 6.6 Japan
  • 6.6.1 Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 6.6.2 Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
  • 6.6.3 Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2025 vs 2032
• 6.7 South Korea
  • 6.7.1 South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 6.7.2 South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
  • 6.7.3 South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2025 vs 2032
• 6.8 India
  • 6.8.1 India Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 6.8.2 India Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
  • 6.8.3 India Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2025 vs 2032
• 6.9 Southeast Asia
  • 6.9.1 Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021-2032
  • 6.9.2 Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
  • 6.9.3 Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application, 2025 vs 2032

7 Key Players Profiles

• 7.1 Lonza
  • 7.1.1 Lonza Company Details
  • 7.1.2 Lonza Business Overview
  • 7.1.3 Lonza Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.1.4 Lonza Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.1.5 Lonza Recent Development
• 7.2 Catalent
  • 7.2.1 Catalent Company Details
  • 7.2.2 Catalent Business Overview
  • 7.2.3 Catalent Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.2.4 Catalent Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.2.5 Catalent Recent Development
• 7.3 Thermo Fisher Scientific
  • 7.3.1 Thermo Fisher Scientific Company Details
  • 7.3.2 Thermo Fisher Scientific Business Overview
  • 7.3.3 Thermo Fisher Scientific Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.3.4 Thermo Fisher Scientific Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.3.5 Thermo Fisher Scientific Recent Development
• 7.4 Samsung Biologics
  • 7.4.1 Samsung Biologics Company Details
  • 7.4.2 Samsung Biologics Business Overview
  • 7.4.3 Samsung Biologics Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.4.4 Samsung Biologics Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.4.5 Samsung Biologics Recent Development
• 7.5 Fareva
  • 7.5.1 Fareva Company Details
  • 7.5.2 Fareva Business Overview
  • 7.5.3 Fareva Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.5.4 Fareva Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.5.5 Fareva Recent Development
• 7.6 WuXi AppTech
  • 7.6.1 WuXi AppTech Company Details
  • 7.6.2 WuXi AppTech Business Overview
  • 7.6.3 WuXi AppTech Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.6.4 WuXi AppTech Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.6.5 WuXi AppTech Recent Development
• 7.7 WuXi Biologics
  • 7.7.1 WuXi Biologics Company Details
  • 7.7.2 WuXi Biologics Business Overview
  • 7.7.3 WuXi Biologics Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.7.4 WuXi Biologics Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.7.5 WuXi Biologics Recent Development
• 7.8 Siegfried
  • 7.8.1 Siegfried Company Details
  • 7.8.2 Siegfried Business Overview
  • 7.8.3 Siegfried Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.8.4 Siegfried Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.8.5 Siegfried Recent Development
• 7.9 FUJIFILM Diosynth Biotechnologies
  • 7.9.1 FUJIFILM Diosynth Biotechnologies Company Details
  • 7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
  • 7.9.3 FUJIFILM Diosynth Biotechnologies Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
• 7.10 Asymchem
  • 7.10.1 Asymchem Company Details
  • 7.10.2 Asymchem Business Overview
  • 7.10.3 Asymchem Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.10.4 Asymchem Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.10.5 Asymchem Recent Development
• 7.11 Pfizer CentreOne
  • 7.11.1 Pfizer CentreOne Company Details
  • 7.11.2 Pfizer CentreOne Business Overview
  • 7.11.3 Pfizer CentreOne Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.11.4 Pfizer CentreOne Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.11.5 Pfizer CentreOne Recent Development
• 7.12 Delpharm
  • 7.12.1 Delpharm Company Details
  • 7.12.2 Delpharm Business Overview
  • 7.12.3 Delpharm Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.12.4 Delpharm Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.12.5 Delpharm Recent Development
• 7.13 Recipharm
  • 7.13.1 Recipharm Company Details
  • 7.13.2 Recipharm Business Overview
  • 7.13.3 Recipharm Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.13.4 Recipharm Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.13.5 Recipharm Recent Development
• 7.14 AGC Pharma Chemicals
  • 7.14.1 AGC Pharma Chemicals Company Details
  • 7.14.2 AGC Pharma Chemicals Business Overview
  • 7.14.3 AGC Pharma Chemicals Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.14.4 AGC Pharma Chemicals Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.14.5 AGC Pharma Chemicals Recent Development
• 7.15 Boehringer Ingelheim
  • 7.15.1 Boehringer Ingelheim Company Details
  • 7.15.2 Boehringer Ingelheim Business Overview
  • 7.15.3 Boehringer Ingelheim Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.15.4 Boehringer Ingelheim Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.15.5 Boehringer Ingelheim Recent Development
• 7.16 Vetter Pharma
  • 7.16.1 Vetter Pharma Company Details
  • 7.16.2 Vetter Pharma Business Overview
  • 7.16.3 Vetter Pharma Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.16.4 Vetter Pharma Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.16.5 Vetter Pharma Recent Development
• 7.17 Curia
  • 7.17.1 Curia Company Details
  • 7.17.2 Curia Business Overview
  • 7.17.3 Curia Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.17.4 Curia Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.17.5 Curia Recent Development
• 7.18 Aenova
  • 7.18.1 Aenova Company Details
  • 7.18.2 Aenova Business Overview
  • 7.18.3 Aenova Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.18.4 Aenova Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.18.5 Aenova Recent Development
• 7.19 Porton
  • 7.19.1 Porton Company Details
  • 7.19.2 Porton Business Overview
  • 7.19.3 Porton Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.19.4 Porton Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.19.5 Porton Recent Development
• 7.20 Piramal
  • 7.20.1 Piramal Company Details
  • 7.20.2 Piramal Business Overview
  • 7.20.3 Piramal Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.20.4 Piramal Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.20.5 Piramal Recent Development
• 7.21 Strides Pharma
  • 7.21.1 Strides Pharma Company Details
  • 7.21.2 Strides Pharma Business Overview
  • 7.21.3 Strides Pharma Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.21.4 Strides Pharma Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.21.5 Strides Pharma Recent Development
• 7.22 NextPharma
  • 7.22.1 NextPharma Company Details
  • 7.22.2 NextPharma Business Overview
  • 7.22.3 NextPharma Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.22.4 NextPharma Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.22.5 NextPharma Recent Development
• 7.23 Famar
  • 7.23.1 Famar Company Details
  • 7.23.2 Famar Business Overview
  • 7.23.3 Famar Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.23.4 Famar Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.23.5 Famar Recent Development
• 7.24 Jubilant
  • 7.24.1 Jubilant Company Details
  • 7.24.2 Jubilant Business Overview
  • 7.24.3 Jubilant Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.24.4 Jubilant Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.24.5 Jubilant Recent Development
• 7.25 Alcami
  • 7.25.1 Alcami Company Details
  • 7.25.2 Alcami Business Overview
  • 7.25.3 Alcami Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.25.4 Alcami Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.25.5 Alcami Recent Development
• 7.26 Euroapi
  • 7.26.1 Euroapi Company Details
  • 7.26.2 Euroapi Business Overview
  • 7.26.3 Euroapi Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.26.4 Euroapi Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.26.5 Euroapi Recent Development
• 7.27 Eurofins
  • 7.27.1 Eurofins Company Details
  • 7.27.2 Eurofins Business Overview
  • 7.27.3 Eurofins Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.27.4 Eurofins Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.27.5 Eurofins Recent Development
• 7.28 Avid Bioservices
  • 7.28.1 Avid Bioservices Company Details
  • 7.28.2 Avid Bioservices Business Overview
  • 7.28.3 Avid Bioservices Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.28.4 Avid Bioservices Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.28.5 Avid Bioservices Recent Development
• 7.29 BioVectra
  • 7.29.1 BioVectra Company Details
  • 7.29.2 BioVectra Business Overview
  • 7.29.3 BioVectra Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.29.4 BioVectra Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
• 7.30 CPL
  • 7.30.1 CPL Company Details
  • 7.30.2 CPL Business Overview
  • 7.30.3 CPL Contract Development and Manufacturing Organizations (CDMOs) Introduction
  • 7.30.4 CPL Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026)
  • 7.30.5 CPL Recent Development

8 Industry Chain Analysis

• 8.1 Contract Development and Manufacturing Organizations (CDMOs) Value Chain
• 8.2 Contract Development and Manufacturing Organizations (CDMOs) Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Key Suppliers of Raw Materials
  • 8.2.3 Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream (Customer) Analysis
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Contract Development and Manufacturing Organizations (CDMOs) Sales Model
  • 8.5.2 Sales Channels

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer

• Table 1. Contract Development and Manufacturing Organizations (CDMOs) Market Trends
• Table 2. Contract Development and Manufacturing Organizations (CDMOs) Market Drivers & Opportunities
• Table 3. Contract Development and Manufacturing Organizations (CDMOs) Market Challenges
• Table 4. Contract Development and Manufacturing Organizations (CDMOs) Market Restraints
• Table 5. Global Contract Development and Manufacturing Organizations (CDMOs) Revenue by Company (US$ Million), 2021-2026
• Table 6. Global Contract Development and Manufacturing Organizations (CDMOs) Revenue Market Share by Company (2021-2026)
• Table 7. Key Companies' R&D and Operations Footprint and Headquarters
• Table 8. Key Companies Contract Development and Manufacturing Organizations (CDMOs) Product Type
• Table 9. Key Companies Founded Date for Contract Development and Manufacturing Organizations (CDMOs)
• Table 10. Global Contract Development and Manufacturing Organizations (CDMOs) Companies Market Concentration Ratio (CR5 and HHI)
• Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Contract Development and Manufacturing Organizations (CDMOs) revenue, 2025
• Table 12. Mergers & Acquisitions and Expansion Plans
• Table 13. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
• Table 14. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (US$ Million), 2021-2026
• Table 15. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (US$ Million), 2027-2032
• Table 16. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share in Value by Type (2021-2026)
• Table 17. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share in Value by Type (2027-2032)
• Table 18. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
• Table 19. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (US$ Million), 2021-2026
• Table 20. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (US$ Million), 2027-2032
• Table 21. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share in Value by Application (2021-2026)
• Table 22. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Market Share in Value by Application (2027-2032)
• Table 23. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
• Table 24. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (US$ Million), 2021-2026
• Table 25. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (US$ Million), 2027-2032
• Table 26. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (%), 2021-2026
• Table 27. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Region (%), 2027-2032
• Table 28. Key Countries/Regions Contract Development and Manufacturing Organizations (CDMOs) Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
• Table 29. Key Countries/Regions Contract Development and Manufacturing Organizations (CDMOs) Sales Value, (US$ Million), 2021-2026
• Table 30. Key Countries/Regions Contract Development and Manufacturing Organizations (CDMOs) Sales Value, (US$ Million), 2027-2032
• Table 31. Lonza Company Details
• Table 32. Lonza Business Overview
• Table 33. Lonza Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 34. Lonza Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 35. Lonza Recent Development
• Table 36. Catalent Company Details
• Table 37. Catalent Business Overview
• Table 38. Catalent Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 39. Catalent Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 40. Catalent Recent Development
• Table 41. Thermo Fisher Scientific Company Details
• Table 42. Thermo Fisher Scientific Business Overview
• Table 43. Thermo Fisher Scientific Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 44. Thermo Fisher Scientific Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 45. Thermo Fisher Scientific Recent Development
• Table 46. Samsung Biologics Company Details
• Table 47. Samsung Biologics Business Overview
• Table 48. Samsung Biologics Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 49. Samsung Biologics Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 50. Samsung Biologics Recent Development
• Table 51. Fareva Company Details
• Table 52. Fareva Business Overview
• Table 53. Fareva Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 54. Fareva Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 55. Fareva Recent Development
• Table 56. WuXi AppTech Company Details
• Table 57. WuXi AppTech Business Overview
• Table 58. WuXi AppTech Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 59. WuXi AppTech Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 60. WuXi AppTech Recent Development
• Table 61. WuXi Biologics Company Details
• Table 62. WuXi Biologics Business Overview
• Table 63. WuXi Biologics Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 64. WuXi Biologics Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 65. WuXi Biologics Recent Development
• Table 66. Siegfried Company Details
• Table 67. Siegfried Business Overview
• Table 68. Siegfried Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 69. Siegfried Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 70. Siegfried Recent Development
• Table 71. FUJIFILM Diosynth Biotechnologies Company Details
• Table 72. FUJIFILM Diosynth Biotechnologies Business Overview
• Table 73. FUJIFILM Diosynth Biotechnologies Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 74. FUJIFILM Diosynth Biotechnologies Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 75. FUJIFILM Diosynth Biotechnologies Recent Development
• Table 76. Asymchem Company Details
• Table 77. Asymchem Business Overview
• Table 78. Asymchem Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 79. Asymchem Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 80. Asymchem Recent Development
• Table 81. Pfizer CentreOne Company Details
• Table 82. Pfizer CentreOne Business Overview
• Table 83. Pfizer CentreOne Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 84. Pfizer CentreOne Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 85. Pfizer CentreOne Recent Development
• Table 86. Delpharm Company Details
• Table 87. Delpharm Business Overview
• Table 88. Delpharm Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 89. Delpharm Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 90. Delpharm Recent Development
• Table 91. Recipharm Company Details
• Table 92. Recipharm Business Overview
• Table 93. Recipharm Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 94. Recipharm Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 95. Recipharm Recent Development
• Table 96. AGC Pharma Chemicals Company Details
• Table 97. AGC Pharma Chemicals Business Overview
• Table 98. AGC Pharma Chemicals Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 99. AGC Pharma Chemicals Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 100. AGC Pharma Chemicals Recent Development
• Table 101. Boehringer Ingelheim Company Details
• Table 102. Boehringer Ingelheim Business Overview
• Table 103. Boehringer Ingelheim Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 104. Boehringer Ingelheim Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 105. Boehringer Ingelheim Recent Development
• Table 106. Vetter Pharma Company Details
• Table 107. Vetter Pharma Business Overview
• Table 108. Vetter Pharma Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 109. Vetter Pharma Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 110. Vetter Pharma Recent Development
• Table 111. Curia Company Details
• Table 112. Curia Business Overview
• Table 113. Curia Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 114. Curia Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 115. Curia Recent Development
• Table 116. Aenova Company Details
• Table 117. Aenova Business Overview
• Table 118. Aenova Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 119. Aenova Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 120. Aenova Recent Development
• Table 121. Porton Company Details
• Table 122. Porton Business Overview
• Table 123. Porton Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 124. Porton Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 125. Porton Recent Development
• Table 126. Piramal Company Details
• Table 127. Piramal Business Overview
• Table 128. Piramal Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 129. Piramal Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 130. Piramal Recent Development
• Table 131. Strides Pharma Company Details
• Table 132. Strides Pharma Business Overview
• Table 133. Strides Pharma Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 134. Strides Pharma Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 135. Strides Pharma Recent Development
• Table 136. NextPharma Company Details
• Table 137. NextPharma Business Overview
• Table 138. NextPharma Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 139. NextPharma Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 140. NextPharma Recent Development
• Table 141. Famar Company Details
• Table 142. Famar Business Overview
• Table 143. Famar Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 144. Famar Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 145. Famar Recent Development
• Table 146. Jubilant Company Details
• Table 147. Jubilant Business Overview
• Table 148. Jubilant Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 149. Jubilant Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 150. Jubilant Recent Development
• Table 151. Alcami Company Details
• Table 152. Alcami Business Overview
• Table 153. Alcami Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 154. Alcami Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 155. Alcami Recent Development
• Table 156. Euroapi Company Details
• Table 157. Euroapi Business Overview
• Table 158. Euroapi Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 159. Euroapi Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 160. Euroapi Recent Development
• Table 161. Eurofins Company Details
• Table 162. Eurofins Business Overview
• Table 163. Eurofins Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 164. Eurofins Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 165. Eurofins Recent Development
• Table 166. Avid Bioservices Company Details
• Table 167. Avid Bioservices Business Overview
• Table 168. Avid Bioservices Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 169. Avid Bioservices Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 170. Avid Bioservices Recent Development
• Table 171. BioVectra Company Details
• Table 172. BioVectra Business Overview
• Table 173. BioVectra Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 174. BioVectra Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 175. CPL Company Details
• Table 176. CPL Business Overview
• Table 177. CPL Contract Development and Manufacturing Organizations (CDMOs) Product
• Table 178. CPL Revenue in Contract Development and Manufacturing Organizations (CDMOs) Business (2021-2026) & (US$ Million)
• Table 179. CPL Recent Development
• Table 180. Key Raw Materials Lists
• Table 181. Key Suppliers of Raw Materials Lists
• Table 182. Contract Development and Manufacturing Organizations (CDMOs) Downstream Customers
• Table 183. Research Programs/Design for This Report
• Table 184. Key Data Information from Secondary Sources
• Table 185. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value, 2021 vs 2026 vs 2032 (US$ Million)
• Figure 2. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 3. Contract Development and Manufacturing Organizations (CDMOs) Report Years Considered
• Figure 4. Global Contract Development and Manufacturing Organizations (CDMOs) Players Revenue Ranking (US$ Million), 2025
• Figure 5. The 5 and 10 Largest Companies in the World: Market Share by Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2025
• Figure 6. The 10 Largest Companies in the World: Market Share by Contract Development and Manufacturing Organizations (CDMOs) Revenue in 2025
• Figure 7. API CDMO Picture
• Figure 8. FDF CDMO Picture
• Figure 9. Packaging CDMO Picture
• Figure 10. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (US$ Million), 2021-2032
• Figure 11. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value Market Share by Type, 2025
• Figure 12. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value Market Share by Type, 2032
• Figure 13. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (US$ Million), 2021-2032
• Figure 14. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value Market Share byApplication,2025
• Figure 15. Global Contract Development and Manufacturing Organizations (CDMOs) Sales Value Market Share by Application, 2032
• Figure 16. North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 17. North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032
• Figure 18. Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 19. Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032
• Figure 20. Asia Pacific Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 21. Asia Pacific Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Subregion (%), 2025 vs 2032
• Figure 22. South America Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 23. South America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032
• Figure 24. Middle East & Africa Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 25. Middle East & Africa Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Country (%), 2025 vs 2032
• Figure 26. North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 27. North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
• Figure 28. North America Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2025 vs 2032
• Figure 29. Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 30. Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
• Figure 31. Europe Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2025 vs 2032
• Figure 32. China Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 33. China Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
• Figure 34. China Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2025 vs 2032
• Figure 35. Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 36. Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
• Figure 37. Japan Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2025 vs 2032
• Figure 38. South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 39. South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
• Figure 40. South Korea Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2025 vs 2032
• Figure 41. India Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 42. India Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
• Figure 43. India Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2025 vs 2032
• Figure 44. Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value (US$ Million), 2021-2032
• Figure 45. Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Type (%), 2025 vs 2032
• Figure 46. Southeast Asia Contract Development and Manufacturing Organizations (CDMOs) Sales Value by Application (%), 2025 vs 2032
• Figure 47. Contract Development and Manufacturing Organizations (CDMOs) Value Chain
• Figure 48. Contract Development and Manufacturing Organizations (CDMOs) Cost Structure
• Figure 49. Global Contract Development and Manufacturing Organizations (CDMOs) Players Revenue Ranking (US$ Million), 2025
• Figure 50. Bottom-up and Top-down Approaches for This Report
• Figure 51. Data Triangulation
• Figure 52. Key Executives Interviewed